Skip to content
Use caution Drug recall · FDA · Published May 1, 2018

AuroMedics Piperacillin-Tazobactam Injection Recall: Visible Particulate Matter Hazard

AuroMedics Pharma recalls single-dose vials of Piperac:illin-Tazobactam injection due to confirmed visible particulate matter (glass) in some units. This may cause serious injury during IV administration. Affected units have specific NDC and lot numbers.

🇺🇸 FDA recall #D-0926-2018DrugAuroMedics ›
Take action

Contact the company

Recalling firmAuroMedics Pharma LLC279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401
✎ GovInfoNow plain-language explainer

AuroMedics Pharma recalled single-dose vials of Piperacillin-Tazobactam injection for possible glass particles that could cause serious injury during IV use. The recall affects specific batches manufactured in 2018-2019. Read more at govinfonow.com/recall/40581-auromedics-piperacillin-tazobactam-injection-recall-visible-particulate-matter-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/40581-auromedics-piperacillin-tazobactam-injection-recall-visible-particulate-matter-hazard · Updated October 7, 2026 · FDA enforcement record: FDA #D-0926-2018

Cite this page

“AuroMedics Piperacillin-Tazobactam Injection Recall: Visible Particulate Matter Hazard.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40581-auromedics-piperacillin-tazobactam-injection-recall-visible-particulate-matter-hazard. Based on FDA recall #D-0926-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0926-2018%22&limit=1).

AuroMedics Pharma LLC voluntarily recalled Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial on May 1, 2018, due to the presence of glass particulate matter, according to the FDA. The recall affects 77,400 vials distributed nationwide.

How to tell if you have it

  • Brand: AuroMedics
  • Product: Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only
  • NDC: 55150-120-30
  • Lot codes: PP0317061-A, PP0317049-A
  • Expiration date: August 2019

The hazard

The recall was initiated after a confirmed customer report of visible particulate matter, which was identified as glass. The FDA classified this as a Class I recall.

Context

GovInfoNow's records show AuroMedics Pharma LLC has issued 22 other recalls since December 4, 2017. Recent recalls include a subpotent drug risk for Fondaparinux Injection on September 30, 2022, and particulate matter hazards for Tranexamic Acid Injection and Acyclovir Injection on September 26, 2022. Other recent recalls of similar products include American Regent Aminocaproic Acid Injection Recall (July 24, 2026), American Regent Papaverine HCl Injection Recall (July 24, 2026), and Mallinckrodt Acthar Gel 5mL Vial Recall (August 6, 2026).

How to tell if you have this one

Check for vials labeled 'Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx'. The NDC number is 55150-120-30 with lot numbers PP0317061-A or PP0317049-A.

  • Brand
    AuroMedics
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Label

    Look for the NDC number 55150-120-30 and lot numbers PP0317061-A or PP0317049-A on the vial.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 5.1 years after the firm started it.

1. Firm started the recall: May 1, 201812. Published in FDA’s Enforcement Report: May 23, 201823. FDA classified it Class I: Jul 17, 201834. FDA terminated the recall: Jun 21, 2023420182023
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class I
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0926-2018 (May 1, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0926-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA